41 Best Cryotherapy Doctors Abroad

Dr. Murat Dokdok is a specialized interventional radiologist at Anadolu Medical Center. He completed an interventional neuroradiology fellowship at the University Hospital of Zurich. Dr. Dokdok also held a fellowship at Harvard Medical School. He focuses on neurological therapy and imaging for conditions like cerebral aneurysms and liver cancer. Dr. Dokdok works at Anadolu, a facility affiliated with Johns Hopkins Medicine.

• Holds over 100 national and international scientific publications and presentations.
• Certified by the European Society of Neuroradiology.
• Member of the Cardiovascular and Interventional Radiology Society of Europe.
• Performs radiofrequency ablation and chemoembolization for oncology patients.

Dr. Agusti Barnadas Molins is the chief breast cancer specialist at Teknon Oncology Institute in Barcelona. He has directed more than 70 research projects on breast cancer and gynecological oncology. Dr. Barnadas Molins treats tumors using chemotherapy, gland therapy, and immunotherapy. He practices at JCI-accredited Centro Médico Teknon.

• Authored over 130 original scientific articles on clinical oncology.
• Served as General Secretary of the Spanish Medical Oncology Society.
• Former President of the Catalan-Balearic Oncology Society.
• Founder and Vice President of the Spanish Breast Cancer Research Group.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Associate Professor Muhammet Derda Ozer specializes in ophthalmic conditions requiring cryotherapy, with advanced training from Wills Eye Institute.

• Completed ophthalmic oncology observership at prestigious Wills Eye Institute in the US
• International Council of Ophthalmology fellowship in vitreo-retinal surgery
• Active researcher with multiple presentations on ocular surface treatments
• Associate professor at Istanbul Yeni Yuzyil University Faculty of Medicine

Dr. Ari Raphael leads groundbreaking clinical trials in oncology, including innovative cryotherapy applications at Sourasky Medical Center.

• Senior lecturer with extensive research in genomics and biomedical informatics
• Primary investigator for multiple oncology clinical trials, including intra-tumoral injections
• Recognized as outstanding teacher by Tel-Aviv University's medical faculty
• Member of prestigious organizations including ESMO and IASLC
• Specializes in thoracic malignancies and advanced treatment protocols

Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in cryotherapy for complex cases.

• Over 41 years of experience in orthopedic oncology
• Fellowship-trained in sarcoma treatment at Institut Gustave Roussy, Paris
• Member of ESMO Sarcoma group faculty
• Published extensive research on bone and soft tissue tumors

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Mustafa Ozdogan is a professor and medical oncology specialist at Memorial Göztepe Hospital. He is the current President of the Antalya Breast Cancer Association. Dr. Ozdogan previously led oncology departments at Memorial Antalya and Medstar Antalya hospitals. He focuses on a multidisciplinary approach to complex cancer care.

• Sits on the board of the Turkish Society of Medical Oncology.
• Maintains active membership in ESMO and ASCO.
• Co-chairs the national working group for head and neck cancers.
• Works at Memorial Göztepe, which features MR Linac and robotic surgery systems.

Dr. Mustafa Solak specializes in cryotherapy for various cancers, trained at Hacettepe University Cancer Institute and Sisli Etfal Research Hospital.

• Expertise in breast, testicular, ovarian, and lung cancers
• Fellowship-trained at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Handles complex cases with cryotherapy

Dr. Dror Levin is a leading expert in treating bone cancer (sarcoma) in children, with specialized training from Italy's top orthopedic center.

• Director of pediatric hematology oncology at Sourasky Medical Center
• Specializes in bone and soft tissue sarcomas
• Trained at Rizzoli Orthopaedic Institute – a world leader in oncology
• Member of ISPHO (Israel's pediatric hemato-oncology association)

Dr. Mustafa Serkan Alemdar specializes in medical oncology with a robust background in internal medicine.

• Completed medical oncology training at Akdeniz University Faculty of Medicine
• Extensive experience across various renowned hospitals in Turkey
• Focuses on delivering personalized oncology treatments

Nearly 10,000 cryosurgery procedures performed – Prof. Niu Lizhi leads Fuda Cancer Hospital's pioneering cryotherapy program.

• President of Fuda Cancer Hospital with 30 years in oncology
• Vice-President of the Asian and International Societies of Cryosurgery
• Specialist in combining cryotherapy with NanoKnife techniques
• Recipient of World Cancer Congress award for cryosurgery advances
• Author of 100+ research papers on minimally invasive cancer treatments

Dr. Christiane Thallinger specializes in skin cancer treatments, including cryotherapy, with over 27 years of experience at Wiener Privatklinik.

• Expert in melanoma, basal cell carcinoma, and squamous cell carcinoma
• Trained in dermoscopy and digital mole mapping for precise diagnostics
• Focuses on dermatologic side effects of cancer therapies
• Member of the Medical University of Vienna's oncology collaborations

Dr. Seehirunwong is a diagnostic radiologist with extensive training in interpreting medical imaging and performing imaging-guided procedures at Intrarat Hospital.

• Specializes in diagnostic radiology and interventional radiology techniques
• Holds a certificate from the Faculty of Medicine, Prince of Songkla University
• Expert in comparing imaging results with other diagnostic tests
• Provides comprehensive consultations for test results and treatment options

Dr. Hasan Anıl Atalay is a urologist focused on uro‑oncology, reconstructive urology, and stone disease. He has expertise in laparoscopic and robotic surgery. He trained at Cerrahpaşa Faculty of Medicine and Istanbul Training & Research Hospital. He completed advanced training at Memorial Sloan Kettering Cancer Center (2010–2011) and World Laparoscopy Hospital (2019–2020).

He has authored more than 30 peer‑reviewed papers (2016–2021). Topics include CT texture to predict ESWL outcomes, VI‑RADS in bladder cancer, renal function after partial nephrectomy, PCNL fluoroscopy and stone metrics, sexual dysfunction, urosepsis biomarkers, and 3D models for PCNL and patient education. He is a member of the European Urology Association, the Turkish Urology Association, and the Urological Surgery Association.